Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free AFIB Stock Alerts

Acutus Medical (AFIB) Competitors

Acutus Medical logo
$0.0001 0.00 (0.00%)
As of 07/2/2026 09:30 AM Eastern
Compare

AFIB vs. TTOO, UTRS, MOTS, DRTSW, and ANZUW

Should you buy Acutus Medical stock or one of its competitors? MarketBeat compares Acutus Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Acutus Medical include T2 Biosystems (TTOO), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry.

How does Acutus Medical compare to T2 Biosystems?

Acutus Medical (NASDAQ:AFIB) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, media sentiment, dividends, profitability and risk.

Acutus Medical has a net margin of -272.74% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
T2 Biosystems -563.16%N/A -174.06%

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
T2 Biosystems Neutral

56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 0.0% of T2 Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Acutus Medical has a beta of 5.67, meaning that its share price is 467% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 7.71, meaning that its share price is 671% more volatile than the broader market.

T2 Biosystems has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than T2 Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
T2 Biosystems$7.68M0.01-$50.08M-$3.89N/A

Summary

T2 Biosystems beats Acutus Medical on 6 of the 11 factors compared between the two stocks.

How does Acutus Medical compare to Minerva Surgical?

Acutus Medical (NASDAQ:AFIB) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Acutus Medical has a beta of 5.67, meaning that its share price is 467% more volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.92, meaning that its share price is 192% more volatile than the broader market.

Minerva Surgical has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 8.5% of Minerva Surgical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Minerva Surgical Neutral

Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Minerva Surgical N/A N/A N/A

Summary

Minerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

How does Acutus Medical compare to Motus GI?

Motus GI (NASDAQ:MOTS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Acutus Medical Neutral

Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

20.1% of Motus GI shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Motus GI has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.67, meaning that its share price is 467% more volatile than the broader market.

Motus GI has higher earnings, but lower revenue than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Summary

Motus GI beats Acutus Medical on 6 of the 11 factors compared between the two stocks.

How does Acutus Medical compare to Alpha Tau Medical?

Acutus Medical (NASDAQ:AFIB) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Alpha Tau Medical has lower revenue, but higher earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Alpha Tau Medical Neutral

Alpha Tau Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Alpha Tau Medical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Alpha Tau Medical N/A N/A N/A

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Acutus Medical and Alpha Tau Medical tied by winning 3 of the 6 factors compared between the two stocks.

How does Acutus Medical compare to Anzu Special Acquisition Corp I?

Anzu Special Acquisition Corp I (NASDAQ:ANZUW) and Acutus Medical (NASDAQ:AFIB) are both medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Anzu Special Acquisition Corp I has higher earnings, but lower revenue than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

In the previous week, Anzu Special Acquisition Corp I's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Anzu Special Acquisition Corp I Neutral
Acutus Medical Neutral

Anzu Special Acquisition Corp I has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Anzu Special Acquisition Corp I's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Anzu Special Acquisition Corp IN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

Summary

Anzu Special Acquisition Corp I and Acutus Medical tied by winning 3 of the 6 factors compared between the two stocks.

Get Acutus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFIB vs. The Competition

Export
MetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$3K$46.05M$7.16B$12.48B
Dividend YieldN/A1.08%2.66%6.52%
P/E Ratio0.0020.7528.0224.70
Price / Sales0.0031.08540.5599.42
Price / CashN/A18.8649.2657.09
Price / Book0.008.4610.966.46
Net Income-$81.66M-$20.01M$3.57B$337.01M
7 Day PerformanceN/A4.17%2.12%1.69%
1 Month PerformanceN/A5.11%5.25%3.81%
1 Year PerformanceN/A-3.58%33.29%23.90%

Acutus Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFIB
Acutus Medical
N/A$0.00
flat		N/AN/A$3K$7.16MN/A340
TTOO
T2 Biosystems
N/A$0.00
-86.7%		N/A-98.6%$8K$7.68MN/A180
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
DRTSW
Alpha Tau Medical
N/A$1.84
-1.1%		N/A+1,322.1%$0.00N/AN/A80

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AFIB) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel